SKI Market

A+| A| A-|

Indian Indices

Sensex

76,503.60 -1,677.12
( -2.15%)

Global Indices

Nasdaq

52,927.94 -148.97
(-0.28%)

Dow Jones

7,522.05 -36.38
(-0.48%)

Hang Seng

67,213.51 -1,043.45
(-1.53%)

Nikkei 225

10,469.05 -196.83
(-1.85%)

Forex

USD-INR

95.36 0.17
(0.18%)

EUR-INR

108.98 0.13
(0.12%)

GBP-INR

127.38 0.36
(0.28%)

JPY-INR

0.59 0.00
(-0.24%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

276.4035981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

37.2

919.15

EPS(TTM)

Face Value()

Div & Yield %

20.97

0.06

Back

Space Incubatrics Technologies reports standalone net loss of Rs 0.19 crore in the December 2025 quarter

Feb 06,2026

Net Loss of Space Incubatrics Technologies reported to Rs 0.19 crore in the quarter ended December 2025 as against net loss of Rs 0.08 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 and during the previous quarter ended December 2024.

76,503.60 -1,677.12 ( -2.15%)

52,927.94 -148.97 (-0.28%)

7,522.05 -36.38 (-0.48%)

67,213.51 -1,043.45 (-1.53%)

10,469.05 -196.83 (-1.85%)

95.36 0.17 (0.18%)

108.98 0.13 (0.12%)

127.38 0.36 (0.28%)

0.59 0.00 (-0.24%)